Article Text

Download PDFPDF

1105 Persistent neuroinflammation in SLE
  1. Bruce Volpe,
  2. Kaitlin Carroll,
  3. Mark Mizrachi,
  4. Meggan Mackay,
  5. An Vo,
  6. David Eidelberg,
  7. Pina Sanelli,
  8. Cynthia Aranow and
  9. Betty Diamond
  1. SLE is a remitting and relapsing disease. Some patients even experience a clinical remission permitting them to cease using all immunosuppressive medication. Interestingly, while these individuals have no evidence of ongoing systemic inflammation, they do often exhibit manifestations of neuroinflammation

Abstract

To understand how neuroinflammation is sustained in the absence of systemic inflammation we have studied a mouse model of neuropsychiatric lupus (NPSLE) which is triggered by the penetration of neurotoxic antibodies into the hippocampus. The subsequent activation of microglia leads to dendritic pruning of hippocampal neurons. This process becomes continuous as the neurons with reduced dendritic arborization secrete HMGB1 which contributes to neuroinflammation through two independent mechanisms. First, it binds NMDA receptors forming a bridge for C1q to decorate synapses to target them for pruning. Second, it activates microglia to secrete C1q. Thus, there is a feed forward loop with activated microglia engaging in dendritic pruning. The resulting neuronal damage leads to increased secretion of HMGB1, which in turn activates microglia. In mice, this inflammatory cycle can be sustained for at least a year. ACE inhibitors, which correct the cognitive deficit in this model, act in part by increasing expression of LAIR-1, an inhibitory receptor for C1q on microglia. This converts C1q from an eat me signal into an immunosuppressive signal.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.